Muddasir Ayaz (@thegastrologer) 's Twitter Profile
Muddasir Ayaz

@thegastrologer

Gastroenterologist @ROCregional, husband, father. CA 🌞➡️(@amherstcollege/@NYUMed/@UNC➡️@UBuffalo_GI ❄️ love 📖 🏋🏽‍♂️🏀🦬🏈

ID: 1337099618602151946

calendar_today10-12-2020 18:19:38

1,1K Tweet

1,1K Followers

965 Following

Evidence-Based GI: An ACG Publication (EBGI) (@acg_ebgi) 's Twitter Profile Photo

🚨SPECIAL ANNOUNCEMENT🚨 In light of ✨Colorectal Cancer Awareness Month✨, EBGI is proud to present: 💙🩵Surviving Colon Cancer🩵💙 Featuring: 🌟Dr. Clive Miranda - EBGI Ambassador 🌟Dr. Amanda Duggan - Colon Cancer Survivor Watch the exclusive interview 🧵 below👇🏻

🚨SPECIAL ANNOUNCEMENT🚨

In light of ✨Colorectal Cancer Awareness Month✨, EBGI is proud to present:

💙🩵Surviving Colon Cancer🩵💙

Featuring:
🌟Dr. Clive Miranda - EBGI Ambassador
🌟Dr. Amanda Duggan - Colon Cancer Survivor

Watch the exclusive interview 🧵 below👇🏻
Muddasir Ayaz (@thegastrologer) 's Twitter Profile Photo

Study confirms that FIT certainly increases engagement with colonoscopy and screening certainly decreases CRC mortality Main point is screening > no screening The details of that screening are less important #GITwitter

Michael "Mike" Albert, MD (@michaelalbertmd) 's Twitter Profile Photo

What really happens when patients stop GLP-1s like semaglutide or tirzepatide? A new systematic review & meta-analysis in Obesity Reviews has answers—and they’re critical for anyone treating obesity as a chronic disease. TLDR: "Discontinuation of GLP-1RA treatment leads to

What really happens when patients stop GLP-1s like semaglutide or tirzepatide?
A new systematic review & meta-analysis in Obesity Reviews has answers—and they’re critical for anyone treating obesity as a chronic disease.

TLDR: "Discontinuation of GLP-1RA treatment leads to
Muddasir Ayaz (@thegastrologer) 's Twitter Profile Photo

Really didn’t think I’d read this much about 🦷 as a GI but here we are! TLDR; brush your teeth! Some microbial benefit when it comes to Crohn’s, cancer etc #GITwitter journals.lww.com/ajg/abstract/9…

Muddasir Ayaz (@thegastrologer) 's Twitter Profile Photo

Sometimes seeing is believing and sometimes thinking is believing ! TLDR; if you imagine how much you just ate you’re less likely to snack later sciencedirect.com/science/articl…

Muddasir Ayaz (@thegastrologer) 's Twitter Profile Photo

Sign of the times! Many issues, lots of confounding and edge cases by the proof of principle hard to ignore ai.nejm.org/doi/full/10.10…

GIE (@gie_journal) 's Twitter Profile Photo

Original Article detailed on the blog: "Duodenoscopy-assisted diagnosis and management of a duodenal varix" by Kar Wai Lau endoscopedia.com/2025/04/22/lau/

Original Article detailed on the blog: "Duodenoscopy-assisted diagnosis and management of a duodenal varix" by Kar Wai Lau endoscopedia.com/2025/04/22/lau/
Muddasir Ayaz (@thegastrologer) 's Twitter Profile Photo

Interesting article - Confounders aplenty but it does speak to the intertwined nature of consumption and risk of malignancy which itself is always a fascinating topic ‼️ #GITwitter rdcu.be/emSFK

VideoGIE Journal (@videogie) 's Twitter Profile Photo

From this month's issue of VideoGIE: "Use of a knotted guidewire to manage duodenoscope working channel obstruction" by Jun Kubota et al. videogie.org/article/S2468-… #GITwitter

From this month's issue of VideoGIE: "Use of a knotted guidewire to manage duodenoscope working channel obstruction" by Jun Kubota et al. videogie.org/article/S2468-…

#GITwitter
Tom Tielleman, MD (@tomtielleman) 's Twitter Profile Photo

Building a program isn't just about being able to do a procedure. I was messaged asking about resection after this lesion was found on FIT+ colon. Years of communication, education, & discussion about what our #ThirdSpace program has to offer led to this patient having a

Building a program isn't just about being able to do a procedure. I was messaged asking about resection after this lesion was found on FIT+ colon. Years of communication, education, & discussion about what our #ThirdSpace program has to offer led to this patient having  a
American Gastroenterological Association (AGA) (@amergastroassn) 's Twitter Profile Photo

Our new clinical practice update in CGH offers insights from authors Seth Crockett and Darrell Pardi on diagnosing and treating sclerosing mesenteritis — a rare, often asymptomatic condition of the bowel mesentery. 📄Read more here: ow.ly/W66l50VVfkI. #GItwitter

Our new clinical practice update in <a href="/AGA_CGH/">CGH</a> offers insights from authors <a href="/seth_crockett/">Seth Crockett</a> and <a href="/DarrellPardi/">Darrell Pardi</a> on diagnosing and treating sclerosing mesenteritis — a rare, often asymptomatic condition of the bowel mesentery. 📄Read more here:  ow.ly/W66l50VVfkI.

#GItwitter
Klaus Mönkemüller, MD, PhD (@kmonkemuller) 's Twitter Profile Photo

✅ Fasting-mimicking diet (FMD) boosts the antitumour immune response in patients with colon cancer 🦠 B. pseudolongum contributes to the FMD antitumour effects in CRC by producing L-arginine. B. pseudolongum is a potential CRC therapeutic strategy.i gut.bmj.com/content/74/5/7…

✅ Fasting-mimicking diet (FMD) boosts the antitumour immune response in patients with colon cancer

🦠 B. pseudolongum contributes to the FMD antitumour effects in CRC by producing L-arginine. B. pseudolongum is a potential CRC therapeutic strategy.i

gut.bmj.com/content/74/5/7…
Keith Siau (@drkeithsiau) 's Twitter Profile Photo

Sites of endoscopy related injury in endoscopists, based on the most comprehensive meta-analysis to date 📍 📸: UEGJ onlinelibrary.wiley.com/doi/10.1002/ue…

Sites of endoscopy related injury in endoscopists, based on the most comprehensive meta-analysis to date 📍

📸: <a href="/UEGJournal/">UEGJ</a> 
onlinelibrary.wiley.com/doi/10.1002/ue…
Muddasir Ayaz (@thegastrologer) 's Twitter Profile Photo

With respect and for the sake of academic discussion - The shield test, advertised as a blood test to detect colorectal cancer, is a terrible test As a screening test, if you miss 45% of stage I colorectal cancer, then you aren’t really screening for cancer #GITwitter

With respect and for the sake of academic discussion -

The shield test, advertised as a blood test to detect colorectal cancer, is a terrible test 

As a screening test, if you miss 45% of stage I colorectal cancer, then you aren’t really screening for cancer

#GITwitter